213 related articles for article (PubMed ID: 36459078)
21. Mitochondrial DNA mutations in head and neck cancer are infrequent and lack prognostic utility.
Challen C; Brown H; Cai C; Betts G; Paterson I; Sloan P; West C; Birch-Machin M; Robinson M
Br J Cancer; 2011 Apr; 104(8):1319-24. PubMed ID: 21427725
[TBL] [Abstract][Full Text] [Related]
22. Letter to the editor: "Liquid biopsy based on saliva cell-free DNA as a potential biomarker for head and neck cancer".
Rapado-González Ó; Muinelo-Romay L; Suárez-Cunqueiro MM
Oral Oncol; 2021 Jan; 112():105016. PubMed ID: 32972862
[No Abstract] [Full Text] [Related]
23. MitoQuicLy: A high-throughput method for quantifying cell-free DNA from human plasma, serum, and saliva.
Michelson J; Rausser S; Peng A; Yu T; Sturm G; Trumpff C; Kaufman BA; Rai AJ; Picard M
Mitochondrion; 2023 Jul; 71():26-39. PubMed ID: 37172669
[TBL] [Abstract][Full Text] [Related]
24. Salivary MicroRNAs for Early Detection of Head and Neck Squamous Cell Carcinoma: A Case-Control Study in the High Altitude Mestizo Ecuadorian Population.
Salazar-Ruales C; Arguello JV; López-Cortés A; Cabrera-Andrade A; García-Cárdenas JM; Guevara-Ramírez P; Peralta P; Leone PE; Paz-Y-Miño C
Biomed Res Int; 2018; 2018():9792730. PubMed ID: 30584540
[TBL] [Abstract][Full Text] [Related]
25. Comparison of paired cerebrospinal fluid and serum cell-free mitochondrial and nuclear DNA with copy number and fragment length.
Chen A; Li J; Wang L; Huang Q; Zhu J; Wen S; Lyu J; Wu W
J Clin Lab Anal; 2020 Jun; 34(6):e23238. PubMed ID: 32052892
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of DNA methylation levels of
Grossi I; Assoni C; Lorini L; Smussi D; Gurizzan C; Grisanti S; Paderno A; Mattavelli D; Piazza C; Pelisenco IA; De Petro G; Salvi A; Bossi P
Oncol Rep; 2024 Mar; 51(3):. PubMed ID: 38299234
[TBL] [Abstract][Full Text] [Related]
27. A novel saliva-based microRNA biomarker panel to detect head and neck cancers.
Salazar C; Nagadia R; Pandit P; Cooper-White J; Banerjee N; Dimitrova N; Coman WB; Punyadeera C
Cell Oncol (Dordr); 2014 Oct; 37(5):331-8. PubMed ID: 25156495
[TBL] [Abstract][Full Text] [Related]
28. Involvement of Circulating Cell-Free Mitochondrial DNA and Proinflammatory Cytokines in Pathogenesis of Chronic Obstructive Pulmonary Disease and Lung Cancer.
Bulgakova O; Kausbekova A; Kussainova A; Kalibekov N; Serikbaiuly D; Bersimbaev R
Asian Pac J Cancer Prev; 2021 Jun; 22(6):1927-1933. PubMed ID: 34181353
[TBL] [Abstract][Full Text] [Related]
29. Circulating Cell-Free DNA Levels in Psychiatric Diseases: A Systematic Review and Meta-Analysis.
Melamud MM; Buneva VN; Ermakov EA
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834811
[TBL] [Abstract][Full Text] [Related]
30. The role of SPP1 as a prognostic biomarker and therapeutic target in head and neck squamous cell carcinoma.
Cai X; Zhang H; Li T
Int J Oral Maxillofac Surg; 2022 Jun; 51(6):732-741. PubMed ID: 34489157
[TBL] [Abstract][Full Text] [Related]
31. Predicting therapeutic responses in head and neck squamous cell carcinoma from
Wei M; Zhi J; Li L; Wang W
Transl Cancer Res; 2023 Dec; 12(12):3604-3617. PubMed ID: 38197078
[TBL] [Abstract][Full Text] [Related]
32. Integrity and quantity of salivary cell-free DNA as a potential molecular biomarker in oral cancer: A preliminary study.
Rapado-González Ó; López-Cedrún JL; Lago-Lestón RM; Abalo A; Rubin-Roger G; Salgado-Barreira Á; López-López R; Muinelo-Romay L; Suárez-Cunqueiro MM
J Oral Pathol Med; 2022 May; 51(5):429-435. PubMed ID: 35416334
[TBL] [Abstract][Full Text] [Related]
33. Mitochondrial resequencing arrays detect tumor-specific mutations in salivary rinses of patients with head and neck cancer.
Mithani SK; Smith IM; Zhou S; Gray A; Koch WM; Maitra A; Califano JA
Clin Cancer Res; 2007 Dec; 13(24):7335-40. PubMed ID: 18094415
[TBL] [Abstract][Full Text] [Related]
34. Clinical relevance of nine transcriptional molecular markers for the diagnosis of head and neck squamous cell carcinoma in tissue and saliva rinse.
Lallemant B; Evrard A; Combescure C; Chapuis H; Chambon G; Raynal C; Reynaud C; Sabra O; Joubert D; Hollande F; Lallemant JG; Lumbroso S; Brouillet JP
BMC Cancer; 2009 Oct; 9():370. PubMed ID: 19835631
[TBL] [Abstract][Full Text] [Related]
35. Plasma extracellular vesicle microRNA-491-5p as diagnostic and prognostic marker for head and neck squamous cell carcinoma.
Panvongsa W; Siripoon T; Worakitchanon W; Arsa L; Trachu N; Jinawath N; Ngamphaiboon N; Chairoungdua A
Cancer Sci; 2021 Oct; 112(10):4257-4269. PubMed ID: 34273216
[TBL] [Abstract][Full Text] [Related]
36. Epigenetics in the diagnosis and prognosis of head and neck cancer: A systematic review.
Lim I; Tan J; Alam A; Idrees M; Brenan PA; Coletta RD; Kujan O
J Oral Pathol Med; 2024 Feb; 53(2):90-106. PubMed ID: 38316046
[TBL] [Abstract][Full Text] [Related]
37. The implications of gene mutations in salivary DNA for noninvasive diagnosis of head and neck cancer with a focus on oral cancer.
Yang X; Song H; Ji T; Du G; Liu W
Oral Oncol; 2022 Jul; 130():105924. PubMed ID: 35594773
[TBL] [Abstract][Full Text] [Related]
38. MicroRNAs as new biomarkers for human papilloma virus related head and neck cancers.
Wang Y; Wang J; Huang Y
Cancer Biomark; 2015; 15(3):213-8. PubMed ID: 25769448
[TBL] [Abstract][Full Text] [Related]
39. Screening key lncRNAs with diagnostic and prognostic value for head and neck squamous cell carcinoma based on machine learning and mRNA-lncRNA co-expression network analysis.
Hu Y; Guo G; Li J; Chen J; Tan P
Cancer Biomark; 2020; 27(2):195-206. PubMed ID: 31815689
[TBL] [Abstract][Full Text] [Related]
40. Plasma-derived cell-free mitochondrial DNA: A novel non-invasive methodology to identify mitochondrial DNA haplogroups in humans.
Newell C; Hume S; Greenway SC; Podemski L; Shearer J; Khan A
Mol Genet Metab; 2018 Dec; 125(4):332-337. PubMed ID: 30361042
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
